Arcus Biosciences Inc (NYSE:RCUS)

15.81
Delayed Data
As of Dec 06
 +0.14 / +0.89%
Today’s Change
12.95
Today|||52-Week Range
34.93
-23.55%
Year-to-Date
Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study
Dec 05 / Zacks.com - Paid Partner Content